olmitriptan

Olmitriptan is a non-standard pharmaceutical name, likely representing a misspelling of **Olmitoch**, a brand of cardiovascular medications marketed by the Indian generic manufacturer **Mitoch Pharma**. The Olmitoch series includes several generic formulations of **olmesartan medoxomil**, an angiotensin II receptor blocker (ARB) used primarily for the management of hypertension. Marketed products under this brand include combinations such as Olmitoch AM (olmesartan and amlodipine) and Olmitoch AMH (olmesartan, amlodipine, and hydrochlorothiazide). The name olmitriptan does not correspond to any known International Nonproprietary Name (INN) or registered drug; the -triptan suffix typically identifies serotonin 5-HT1B/1D receptor agonists used for migraine treatment, which is inconsistent with the cardiovascular therapeutic class and the manufacturer's product list.

Brand names

OlmitriptanOlmitoch